RhoGAM, a drug developed in the 1960s by Columbia University physicians, prevents one of the most severe and devastating diseases affecting fetuses and newborn babies and is still in use today.
Two new precision medicine tests that look beyond cancer genes to identify novel therapeutic targets are now available to both oncologists and cancer researchers.
CUIMC researchers are helping scientists change the way they study human behavior to focus on the mechanisms that explain how people adopt healthier habits.
In a new article in Science, historians at the Mailman School of Public Health challenge claims that the sugar industry paid scientists in the 1960s to play down the link between sugar and heart disease.
Dennis Mitchell, DDS, was elected to the board of directors of the National Association of Diversity Officers in Higher Education, the most pre-eminent voice for diversity in higher education in the United States.
